Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
American Journal of Medical Genetics. Part A
|
June 7, 2008
Peroxisomal acyl-CoA-oxidase deficiency: two new cases
Rosalba Carrozzo, Carlo Bellini, Simona Lucioli, et al.
Current Pediatric Reviews
|
January 28, 2022
Adenosine Blood Level: A Biomarker of White Matter Damage in Very Low Birth Weight Infants
Marina Colella, Isabella Panfoli, Matteo Doglio, et al.
American Journal of Hematology
|
March 15, 2026
Three-Hour Infusion of Methotrexate at 3 g/m<sup>2</sup> With or Without Intrathecal Chemotherapy Significantly Reduces CNS Relapses and Improves Survival in Patients With Large B-Cell Lymphomas at Increased CNS Risk
Andrés J M Ferreri, Federico Erbella, Piera Angelillo, et al.
Blood Cancer Journal
|
August 29, 2025
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era
Giulio Cassanello, Esther Drill, Annie Qiu, et al.
American Journal of Hematology
|
May 21, 2024
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis
Aseel Alsouqi, Gulrayz Ahmed, Juntian Wang, et al.
Blood Advances
|
October 29, 2024
Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
Yannis K Valtis, Sean Devlin, Roni Shouval, et al.
Haematologica
|
September 5, 2024
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience
Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, et al.
Transplantation and Cellular Therapy
|
July 7, 2024
Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma
Rachel Lorenc, Roni Shouval, Jessica R Flynn, et al.
Blood Cancer Discovery
|
December 12, 2024
Dynamics of Immune Reconstitution and Impact on Outcomes across CAR-T Cell Products in Large B-cell Lymphoma
Danny Luan, Susan DeWolf, Teng Fei, et al.
British Journal of Haematology
|
July 1, 2025
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience
Giulio Cassanello, Efrat Luttwak, Samantha Brown, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
American Journal of Medical Genetics. Part A
|
June 7, 2008
Peroxisomal acyl-CoA-oxidase deficiency: two new cases
Rosalba Carrozzo, Carlo Bellini, Simona Lucioli, et al.
Current Pediatric Reviews
|
January 28, 2022
Adenosine Blood Level: A Biomarker of White Matter Damage in Very Low Birth Weight Infants
Marina Colella, Isabella Panfoli, Matteo Doglio, et al.
American Journal of Hematology
|
March 15, 2026
Three-Hour Infusion of Methotrexate at 3 g/m<sup>2</sup> With or Without Intrathecal Chemotherapy Significantly Reduces CNS Relapses and Improves Survival in Patients With Large B-Cell Lymphomas at Increased CNS Risk
Andrés J M Ferreri, Federico Erbella, Piera Angelillo, et al.
Blood Cancer Journal
|
August 29, 2025
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era
Giulio Cassanello, Esther Drill, Annie Qiu, et al.
American Journal of Hematology
|
May 21, 2024
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis
Aseel Alsouqi, Gulrayz Ahmed, Juntian Wang, et al.
Blood Advances
|
October 29, 2024
Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
Yannis K Valtis, Sean Devlin, Roni Shouval, et al.
Haematologica
|
September 5, 2024
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience
Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, et al.
Transplantation and Cellular Therapy
|
July 7, 2024
Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma
Rachel Lorenc, Roni Shouval, Jessica R Flynn, et al.
Blood Cancer Discovery
|
December 12, 2024
Dynamics of Immune Reconstitution and Impact on Outcomes across CAR-T Cell Products in Large B-cell Lymphoma
Danny Luan, Susan DeWolf, Teng Fei, et al.
British Journal of Haematology
|
July 1, 2025
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience
Giulio Cassanello, Efrat Luttwak, Samantha Brown, et al.
Page
of 8